The Pharmacogenomics Journal - Table of Contents alert Volume 12 Issue 1

TABLE OF CONTENTS Volume 12, Issue 1 (February 2012) In this issue Feature Review Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Therapeutic Innovations Emerging challenges and new successes in the revolution of therapeutics. Translating scientific exploration and discovery to patient care. Read the full issue online.   Advertisement Complete automation solutions from sample to analysis! Join Agilent at SLAS 2012. Explore how Agilent Technologies automates more scientific workflows than ever before with integrated automation solutions for unlimited assay scale-up and sample preparation, an expanded Agilent Bravo platform for ultrafast protein characterization, peptide mapping, glycan analysis, and 30-minute ELISAs and the new Agilent RapidFire for a ten-fold increase in mass spectrometry throughput. Register for our workshops and see the abstracts on our website   Feature Review Top Genomics and pharmacogenomics of pancreatic adenocarcinoma M A Lowery and E M O'Reilly Pharmacogenomics J 2012 12: 1-9; advance online publication, December 20, 2011; 10.1038/tpj.2011.52 Abstract | Full Text Original Articles Top Sequential changes in gene expression profiles in breast cancers during treatment with the aromatase inhibitor, letrozole W R Miller, A Larionov, T J Anderson, D B Evans and J M Dixon Pharmacogenomics J 2012 12: 10-21; advance online publication, August 10, 2010; 10.1038/tpj.2010.67 Abstract | Full Text Effects of OCT1 polymorphisms on the cellular uptake, plasma concentrations and efficacy of the 5-HT3 antagonists tropisetron and ondansetron M V Tzvetkov, A R Saadatmand, K Bokelmann, I Meineke, R Kaiser and J Brockmöller Pharmacogenomics J 2012 12: 22-29; advance online publication, October 5, 2010; 10.1038/tpj.2010.75 Abstract | Full Text A new mouse mutant of the Cdh23 gene with early-onset hearing loss facilitates evaluation of otoprotection drugs F Han, H Yu, C Tian, H E Chen, C Benedict-Alderfer, Y Zheng, Q Wang, X Han and Q Y Zheng Pharmacogenomics J 2012 12: 30-44; advance online publication, July 20, 2010; 10.1038/tpj.2010.60 Abstract | Full Text The genetics of loop diuretic effects S V Vormfelde and J Brockmöller Pharmacogenomics J 2012 12: 45-53; advance online publication, September 28, 2010; 10.1038/tpj.2010.68 Abstract | Full Text Gene–gene interactions of the INSIG1 and INSIG2 in metabolic syndrome in schizophrenic patients treated with atypical antipsychotics Y-J Liou, Y M Bai, E Lin, J-Y Chen, T-T Chen, C-J Hong and S-J Tsai Pharmacogenomics J 2012 12: 54-61; advance online publication, September 28, 2010; 10.1038/tpj.2010.74 Abstract | Full Text Association between HTR2C gene polymorphisms and the metabolic syndrome in patients using antipsychotics: a replication study A J Risselada, J Vehof, R Bruggeman, B Wilffert, D Cohen, A F Al Hadithy, J Arends and H Mulder Pharmacogenomics J 2012 12: 62-67; advance online publication, August 3, 2010; 10.1038/tpj.2010.66 Abstract | Full Text Genome-wide association study of increasing suicidal ideation during antidepressant treatment in the GENDEP project N Perroud, R Uher, M Y M Ng, M Guipponi, J Hauser, N Henigsberg, W Maier, O Mors, M Gennarelli, M Rietschel, D Souery, M Z Dernovsek, A S Stamp, M Lathrop, A Farmer, G Breen, K J Aitchison, C M Lewis, I W Craig and P McGuffin Pharmacogenomics J 2012 12: 68-77; advance online publication, September 28, 2010; 10.1038/tpj.2010.70 Abstract | Full Text Catechol O-methyltransferase pharmacogenomics and selective serotonin reuptake inhibitor response Y Ji, J Biernacka, K Snyder, M Drews, L L Pelleymounter, C Colby, L Wang, D A Mrazek and R M Weinshilboum Pharmacogenomics J 2012 12: 78-85; advance online publication, September 28, 2010; 10.1038/tpj.2010.69 Abstract | Full Text Dopamine D4 receptor gene variation moderates the efficacy of bupropion for smoking cessation A M Leventhal, S P David, M Brightman, D Strong, J E McGeary, R A Brown, E E Lloyd-Richardson, M Munafò, G R Uhl and R Niaura Pharmacogenomics J 2012 12: 86-92; advance online publication, July 27, 2010; 10.1038/tpj.2010.64 Abstract | Full Text Advertisement PGx, Personalized Medicine & the FDA - what you need to know Predict patient response using advanced molecular profiling strategies and increase drug success at the 2nd World PGx Summit (24-26 April '12, Boston). The agenda features case studies and insights from Pfizer, Eli Lilly, J&J, GSK, Novartis, Eisai, Abbott, Genentech, Amgen, MedImmune, BMS, Merck and the FDA.   Advertisement If you are unable to access the articles in this Table of Contents e-alert, your library may not subscribe to The Pharmacogenomics Journal. Library recommendation through our online recommendation form is a simple way to make your librarian aware that this journal is valuable to your research. Recommend now by visiting http://www.nature.com/librec/svc/request/makeProdRequest?id=tpj.   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to The Pharmacogenomics Journal. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.